Step back in time with a look at Ohio’s most memorable bowling alleys, from lost local favorites to the few that still keep ...
ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal ...
Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback